Pharmacotherapy for acute pouchitis;La farmacoterapia de pacientes con pouchitis aguda

Annals of Pharmacotherapy

Volumn 45, Issue 9, 2011, Pages 1127-1137

  Wall, Geoffrey C ^a   Schirmer, Lori L ^a   Anliker, Lynn E ^b   Tigges, Ashley E ^c  

^a DRAKE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ciprofloxacin; Metronidazole; Pouchitis; Ulcerative colitis; VSL 3

Indexed keywords

ALLOPURINOL; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AST 120; AZATHIOPRINE; BISMUTH; BUDESONIDE; CIPROFLOXACIN; ERYTHROMYCIN; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; PROBIOTIC AGENT; RIFAXIMIN; TETRACYCLINE; TINIDAZOLE; VSL3;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ACUTE DISEASE; ALGORITHM; ANASTOMOSIS; ANTIBIOTIC THERAPY; ANUS ANASTOMOSIS; BLOATING; CAPSULE ENDOSCOPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL (TOPIC); CROHN DISEASE; DIARRHEA; DISEASE ACTIVITY; DISEASE COURSE; DRUG CHOICE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG WITHDRAWAL; ENTERITIS; FECES INCONTINENCE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HUMAN; ILEITIS; ILEUM POUCH; INJECTION SITE REACTION; META ANALYSIS (TOPIC); PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RECURRENT DISEASE; REMISSION; REOPERATION; REPEATED DRUG DOSE; REVIEW; SERUM SICKNESS; STEROID THERAPY; SYSTEMATIC REVIEW; TREATMENT INDICATION; ULCERATIVE COLITIS; VOMITING;

ACUTE DISEASE; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; COLONIC POUCHES; HUMANS; INFLAMMATORY BOWEL DISEASES; POUCHITIS; PROBIOTICS; RECURRENCE; TIME FACTORS;

EID: 80052463855     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P790     Document Type: Review

References (35)

1. Grucela A, Steinhagen RM. Current surgical management of ulcerative colitis. Mt Sinai J Med 2009;76:606-12.
2. Persson E, Gustavsson B, Hellström AL, Lappas G, Hultén L. Ostomy patients' perceptions of quality of care. J Adv Nurs 2005;49:51-8.
3. Fry RD, Mahmoud N, Maron DJ, et al. Colon and rectum. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL, eds. Sabiston textbook of surgery. 18th ed. Philadelphia: Saunders, 2008.
4. Bach SP, Mortensen NJM. Revolution and evolution: 30 years of ileoanal pouch surgery. Inflamm Bowel Dis 2006;12:131-45
5. Pardi DS, D'Haens G, Shen B, Campbell S, Gionchetti P. Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis 2009;15: 1424-31.
6. Nicholls RJ, Banerjee AK, Lond MS. Pouchitis: risk factors, etiology and treatment. World J Surg 1998;22:347-51.
7. Coffey JC, Rowan F, Burke J, et al. Pathogenesis of and unifying hypothesis for idiopathic pouchitis. Am J Gastroenterol 2009;104:1013-23
8. Achkar JP, Al-Haddad M, Lashner B, et al. Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 2005;3:60-6
9. Kuhacher T, Schreiber, Runkel N. Pouchitis: pathophysiology and treatment. Int J Colorect Dis 1998;13:196-207.
10. Coffey JC, McCarthy E, Kavanagh E, et al. Pouchitis: an evolving clinical enigma a review. Dis Colon Rectum 2009;52:140-53.
11. Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994;69:409-15.
12. Baert RW. Pouchitis: a clarification. Gastroenterology 1995;109:1022-4.
13. Kmiot WA, Hesslewood SR, Smith N, et al. Evaluation of the inflammatory infiltrate in pouchitis with 111In-labeled granulocytes. Gastroenterology 1993;104:981-8.
14. Madden MV, McIntyre AS, Nicholls RJ. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994;39:1193-6.
15. Shen B, Achkar JP, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001;7:301-5.
16. Isaacs KL, Sandler RS, Abreu M, et al. Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2007;13:1250-5.
17. Abdelrazeq AS, Kelly SM, Lund JN, Leveson SH. Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis. Colorectal Dis 2005;7:182-6.
18. Shen B, Fazio VW, Remzi FH, et al. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis Colon Rectum 2007;50:498-508.
19. Brain O, Travis SP. Therapy of ulcerative colitis: state of the art. Curr Opin Gastroenterol 2008;24:469-74.
20. Miglioli M, Barbara L, Di Febo G, et al. Topical administration of 5aminosalicylic acid: a therapeutic proposal for the treatment of pouchitis. N Engl J Med 1989;320:257.
21. Sambuelli A, Boerr L, Negreira S, et al. Budesonide enema in pouchitis a double-blind, double-dummy, controlled trial. Aliment Pharmacol Ther 2002;16:27-34.
22. Joelsson M, Andersson M, Bark T, et al. Allopurinol as prophylaxis against pouchitis following ileal pouch-anal anastomosis for ulcerative colitis. A randomized placebo-controlled double-blind study. Scand J Gastroenterol 2001;36:1179-84.
23. Shen B, Pardi DS, Bennett AE, et al. The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis. Am J Gastroenterol 2009;104:1468-74.
24. Gionchetti P, Rizzello F, Venturi A, et al. Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis. Aliment Pharmacol Ther 1997;11:673-8.
25. Colombel JF, Ricart E, Loftus EV Jr, et al. Management of Crohn's disease of the ileoanal pouch with infliximab. Am J Gastroenterol 2003;98: 2239-44.
26. Viscido A, Kohn A, Papi C, Caprilli R. Management of refractory fistulizing pouchitis with infliximab. Eur Rev Med Pharmacol Sci 2004;8: 239-46.
27. Calabrese C, Gionchetti P, Rizzello F, et al. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther 2008;27:759-64.
28. Haveran LA, Sehgal R, Poritz LS, McKenna KJ, Stewart DB, Koltun WA. Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA. Dis Colon Rectum 2011;54:15-20.
29. Jones JL, Foxx-Orenstein AE. The role of probiotics in inflammatory bowel disease. Dig Dis Sci 2007;52:607-11.
30. Elahi B, Nikfar S, Derakhshani S, Vafaie M, Abdollahi M. On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. Dig Dis Sci 2008;53:1278-84.
31. Yan F, Polk DB. Probiotics: progress toward novel therapies for intestinal diseases. Curr Opin Gastroenterol 2010;26:95-101.
32. VSL#3 product home page. www.vsl3.com/healthcare.asp (accessed 2010 Feb 19).
33. Mimura T, Helwig U, Schreiber S, Talbot IC, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004:53;108-14.
34. Shen B, Brzezinski A, Fazio VW, Remzi FH, et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther 2005:22;721-8.
35. Shen B, Remzi F, Lopez AR, Queener E. Rifaximin for maintenance therapy in antibiotic-dependent pouchitis. BMC Gastroenterol 2008;8:26.